CORRIGAN MARK

SEC Form 4 insider trading activity

CORRIGAN MARK has filed 1 SEC Form 4 filing (2 transaction rows) across 1 company, with disclosures dating back to 2025. 1 of those filings fall inside the rolling window. Most recent filing: Dec 10, 2025.

On the most recent filing, CORRIGAN MARK is listed as Director at Wave Life Sciences Ltd. Inside the rolling window, CORRIGAN MARK reported no open-market purchases and 1 open-market sale totaling $217K in WVE.

Companies traded

Other insiders at WVE

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$217K

reported sales (SEC code S)

Companies

1

in the rolling window

Source
WVE
CORRIGAN MARK
Sale$217KDec 10SEC ↗
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has CORRIGAN MARK made?

CORRIGAN MARK has filed 1 SEC Form 4 filing (2 transaction rows) across 1 company since 2025.

Which companies does CORRIGAN MARK trade?

CORRIGAN MARK has filed SEC Form 4 disclosures for 1 company, including WVE.

When was CORRIGAN MARK's most recent SEC Form 4 filing?

CORRIGAN MARK's most recent SEC Form 4 filing on Tracefour is dated Dec 10, 2025.

What is CORRIGAN MARK's total buy and sell value in the current window?

Inside the rolling retention window, CORRIGAN MARK bought $0 and sold $217K based on SEC Form 4 filings.

What was CORRIGAN MARK's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 16,115 WVE shares on 2025-12-08, worth $217K, per SEC Form 4 filings.